Clinical Trials Browser

Phase 2 × Standard of Care × 30 days × Clear all

NCT05564390 2026-04-17

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Phase 2 Recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT07535632 2026-04-17

BEST

Phase 2 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms

NCT04870762 2026-04-15

Customized 3D Printed Oral Stents During Head and Neck Radiotherapy

Phase 2 Recruiting

Maxillary Sinus Neoplasms, Mouth Neoplasms, Parotid Neoplasms, Tongue Neoplasms, Tonsillar Neoplasms

NCT06861244 2026-04-13

PNOC031

Phase 2 Recruiting

Neuroectodermal Tumors, Primitive, Pyloric Stenosis, Hypertrophic

NCT07346209 2026-04-08

STRIPe

Phase 2 Not yet recruiting

Neoplasm Metastasis

NCT07512076 2026-04-06

A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT06532279 2026-04-03

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Stomatitis

NCT06401980 2026-03-30

Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Phase 2 Recruiting

Metastatic Castration-resistant Prostate Cancer

NCT05657873 2026-03-27

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung